![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Structured Product Merrill Lynch Dow Jones Euro Stoxx 50 Index Mitts | NYSE:MLB | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.97 | 0.00 | 01:00:00 |
RNS Number:2877J M.L. Laboratories PLC 27 March 2003 ML Laboratories PLC ("the Company") Proposed disposal of the Icodextrin Manufacturing Business and Notice of Extraordinary General Meeting Two copies of the above document which were posted to shareholders yesterday and which contain the notice of the Company's Extraordinary General Meeting to be held on 11 April 2003 and copies of the proxy cards have been submitted to the UK Listing Authority and will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is situated at: Financial Services Authority 25 The North Colonnade Canary Wharf London E14 5HS Tel. No. (020) 7676 1000 For further information, please contact: ML Laboratories PLC Peter Shennan 01925 844 700 27 March, 2003 This information is provided by RNS The company news service from the London Stock Exchange END DOCLDLFLXXBZBBZ
1 Year Mitchells & Butlers Chart |
1 Month Mitchells & Butlers Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions